BioCentury | May 31, 2010
Financial News

Noxxon completes venture financing

...Sofinnova Partners; Edmond de Rothschild Investment Partners; Seventure Partners; VC Fonds Berlin; Dow Venture Capital; Medical BioHealth Trends...
BioCentury | May 28, 2010
Financial News

Noxxon raises EUR 33 million

Noxxon Pharma AG (Berlin, Germany) raised EUR 33 million ($41.2 million) in a series D round led by new investor NGN Capital. Existing investors TVM Capital; Sofinnova Partners; Edmond de Rothschild Investment Partners; Seventure Partners;...
BioCentury | May 7, 2007
Finance

Ebb & Flow

...Beteiligungsgesellschaft Sachsen-Anhalt; and VC Fonds Berlin. They joined existing investors Deutsche Effecten-und Wechsel-Beteiligungsgesellschaft; FCP OP Medical BioHealth Trends...
BioCentury | May 4, 2007
Financial News

Noxxon raises EUR 37 million

...IBG Beteiligungsgesellschaft Sachsen-Anhalt; and VC Fonds Berlin joined existing investors Deutsche Effecten-und Wechsel-Beteiligungsgesellschaft; FCP OP Medical BioHealth Trends...
BioCentury | Feb 17, 2007
Financial News

Ziopharm raises $30.9 million

Cancer company ZIOP raised $30.9 million in a private placement of 5.9 million units at $5.23. Each unit consists of a share and a five-year warrant to purchase 0.2 shares, with each whole share warrant...
BioCentury | May 8, 2006
Finance

Ebb & Flow

...LBI Group; Emerging Technology Partners; Knott Partners; Panacea Asset Management; Cycad Group; Henderson Global Management; Medical Biohealth Trends...
BioCentury | May 4, 2006
Financial News

Ziopharm raises $37 million

...LBI Group; Emerging Technology Partners; Knott Partners; Panacea Asset Management; Cycad Group; Henderson Global Management; Medical Biohealth Trends...
BioCentury | Apr 2, 2001
Finance

Ebb & Flow

For years the industry has struggled to put a valuation on early stage research. Banc of America analyst Jim Reddoch provided a series of benchmarks he uses to value genomics and post-genomics companies, as well...
BioCentury | Mar 30, 2001
Financial News

Micromet raises $35.6 million

Micromet (Martinsried, Germany) raised EUR40 million ($35.6 million) in a venture financing. Investors included Advent Partners; DG Lux ; Medical Biohealth-Trends; PHARMAw/HEALTH; the Wellcome Trust; International Biotechnology Trust; Atlas Venture; Schroder Ventures; 3i; and Abingworth....
Items per page:
1 - 9 of 9
BioCentury | May 31, 2010
Financial News

Noxxon completes venture financing

...Sofinnova Partners; Edmond de Rothschild Investment Partners; Seventure Partners; VC Fonds Berlin; Dow Venture Capital; Medical BioHealth Trends...
BioCentury | May 28, 2010
Financial News

Noxxon raises EUR 33 million

Noxxon Pharma AG (Berlin, Germany) raised EUR 33 million ($41.2 million) in a series D round led by new investor NGN Capital. Existing investors TVM Capital; Sofinnova Partners; Edmond de Rothschild Investment Partners; Seventure Partners;...
BioCentury | May 7, 2007
Finance

Ebb & Flow

...Beteiligungsgesellschaft Sachsen-Anhalt; and VC Fonds Berlin. They joined existing investors Deutsche Effecten-und Wechsel-Beteiligungsgesellschaft; FCP OP Medical BioHealth Trends...
BioCentury | May 4, 2007
Financial News

Noxxon raises EUR 37 million

...IBG Beteiligungsgesellschaft Sachsen-Anhalt; and VC Fonds Berlin joined existing investors Deutsche Effecten-und Wechsel-Beteiligungsgesellschaft; FCP OP Medical BioHealth Trends...
BioCentury | Feb 17, 2007
Financial News

Ziopharm raises $30.9 million

Cancer company ZIOP raised $30.9 million in a private placement of 5.9 million units at $5.23. Each unit consists of a share and a five-year warrant to purchase 0.2 shares, with each whole share warrant...
BioCentury | May 8, 2006
Finance

Ebb & Flow

...LBI Group; Emerging Technology Partners; Knott Partners; Panacea Asset Management; Cycad Group; Henderson Global Management; Medical Biohealth Trends...
BioCentury | May 4, 2006
Financial News

Ziopharm raises $37 million

...LBI Group; Emerging Technology Partners; Knott Partners; Panacea Asset Management; Cycad Group; Henderson Global Management; Medical Biohealth Trends...
BioCentury | Apr 2, 2001
Finance

Ebb & Flow

For years the industry has struggled to put a valuation on early stage research. Banc of America analyst Jim Reddoch provided a series of benchmarks he uses to value genomics and post-genomics companies, as well...
BioCentury | Mar 30, 2001
Financial News

Micromet raises $35.6 million

Micromet (Martinsried, Germany) raised EUR40 million ($35.6 million) in a venture financing. Investors included Advent Partners; DG Lux ; Medical Biohealth-Trends; PHARMAw/HEALTH; the Wellcome Trust; International Biotechnology Trust; Atlas Venture; Schroder Ventures; 3i; and Abingworth....
Items per page:
1 - 9 of 9